Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corp.
Your view on BMGP
Overview
What the company does, where it operates, and who runs it.
About Biomagnetics Diagnostics Corp.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Clayton Hardman
- Headquarters
- 8864 Greenback Lane Suite EOrangevale, 95662United States, Orangevale, US
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Clayton Hardman
- Headquarters
- 8864 Greenback Lane Suite EOrangevale, 95662United States, Orangevale, US
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s diagnostics system focuses on real-time testing for the actual presence of the virus or toxin or disease itself and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear.
The Company’s products include High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and Integrity Optical Biosensor (IOBS). Its HTS-MTP is designed to detect both qualitative chemical identification of the elements present in a substance and quantitative number of specific elements in a substance results from a single test.
The Company triggered optical biosensor that is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Biomagnetics Diagnostics Corp., and the rating behind it. BMGP last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Biomagnetics Diagnostics Corp.. Starting points for Biomagnetics Diagnostics Corp.: beta 2.81 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Biomagnetics Diagnostics Corp.. Biomagnetics Diagnostics Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Biomagnetics Diagnostics Corp.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Biomagnetics Diagnostics Corp.. Biomagnetics Diagnostics Corp. has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Biomagnetics Diagnostics Corp. valued side by side against its closest peers. Biomagnetics Diagnostics Corp. is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Biomagnetics Diagnostics Corp., and how their positions are changing. At a $1,265 market value, institutional positions materially move Biomagnetics Diagnostics Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Biomagnetics Diagnostics Corp. executives and directors. Shares of Biomagnetics Diagnostics Corp. have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Biomagnetics Diagnostics Corp.. Biomagnetics Diagnostics Corp. is a $1,265 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Biomagnetics Diagnostics Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Biomagnetics Diagnostics Corp.. Coverage tracks Biomagnetics Diagnostics Corp. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.